Dec 13, 2022
Increased Risks of Delayed Care Post-Roe: Clinician Perspectives
In the wake of the Dobbs decision, which overturned Roe v. Wade, rapid changes in hospital protocols have at times amplified confusion over what is legally allowed when responding to ectopic pregnancy, miscarriage, or other obstetric complications. Clinicians in some states may feel pinned between their obligation to care for the patient and their obligation not to break the law.
Search
The Tribute Plan Frequently Asked Questions
The Tribute Plan is a breakthrough financial benefit that rewards eligible members for their loyalty to The Doctors Company and for their commitment to superior patient care.
How Could Marginalized Groups Be Impacted by the Digital Divide?
Artificial intelligence (AI) has potential to help alleviate clinician burnout and address health disparities, but some technologies might not be accessible to all groups. Kevin Johnson, MD, MS, University Professor of Biomedical Informatics, Computer Science, Pediatrics, and Science Communication at the University of Pennsylvania, Vice President of Applied Clinical Informatics in the Penn Medicine, University of Pennsylvania Health System, shares insights during TDC Group’s 2024 Executive Advisory Board Meeting.
2025 Legislative Update
Most states adjourned their 2025 regular legislative sessions mid-year. A handful of states remain in regular session and a smattering of states have returned or are expected to convene special sessions to address budget and other issues. While the pace of legislation activity has slowed, TDC Group’s Government Relations team continues to advocate on pending legislation, prepare with coalitions for the 2026 legislative sessions, and engage in key judicial actions warranting an amicus curiae voice.
Jun 05, 2023
Building a Culture of Safety in Healthcare, Part Four: Just Culture
In the final installment of his series on safety culture, Dr. David Feldman describes how a just culture promotes both patient safety and professional satisfaction.
From
The Doctor’s Advocate
October 16, 2022, The Art of Medicine with Dr. Andrew Wilner
Avoiding Medical Malpractice: An Interview with David Feldman, MD, MBA
Dr. David L. Feldman, Chief Medical Officer for The Doctors Company, speaks with Andrew Wilner, MD, FACP, FAAN, Associate Professor of Neurology, The University of Tennessee Health Science Center, on ways to improve patient outcomes and prevent medical malpractice.
Interventional Radiology Wrong-Site Procedure: Case Review
This case review explores factors contributing to a wrong-site procedure and highlights strategies that can help practitioners mitigate risk and increase safety.
Community Oncology Alliance Selects The Doctors Company as Exclusive Medical Malpractice Insurance Partner
The Community Oncology Alliance (COA) has chosen The Doctors Company, part of TDC Group, as the exclusively endorsed medical malpractice insurer for its members.
February 21, 2024, Journal of the American College of Cardiology
Professional Liability: The Problem That Will Not Go Away
The frequency of malpractice claims in the United States has trended downward in the last 10 to 15 years, however, there is an upward trend in the “severity” of claims, driven in large part by “nuclear” jury verdicts. Cardiologists and other clinicians should always be aware that a lack of communication is a common causal factor in malpractice suits. Richard E. Anderson, MD, FACP, Chairman and CEO, The Doctors Company and TDC Group, investigates claim amounts and severity alongside three prominent physicians.
December 01, 2024, South Florida Hospital News and Healthcare Report
The Rising Threat of Nuclear Verdicts in Medical Malpractice: A Call for Tort Reform
Dr. Patricia Ares-Romero discusses the increasing trend of "nuclear verdicts"—jury awards exceeding $10 million—in medical malpractice cases. She highlights insights from Bob White, President of The Doctors Company and TDC Group, noting that from 2013 to 2023, these verdicts surged by 67%, with the average award among the top 50 malpractice verdicts rising from $32 million in 2022 to $48 million in 2023.
